论文部分内容阅读
目的:探究阿伐他汀联合曲美他嗪治疗冠心病的临床应用效果。方法:对2010年6月至2014年6月在我院心内科治疗的冠心病患者76例患者进行回顾性分析,根据患者的用药方案分为对照组和观察组分别38例,对照组患者采用阿伐他汀治疗,治疗组患者则采用阿伐他汀联合曲美他嗪进行治疗,对比两组患者的临床治疗效果。结果:治疗组患者的临床治疗有效率为97.4%,对照组患者的临床治疗有效率为73.7%,治疗组治疗效果明显优于对照组,差异显著具有统计意义(P<0.05)。结论:在冠心病的临床治疗中应用阿伐他汀联合曲美他嗪进行治疗能够显著提升其临床治疗效果,值得在临床上推广应用。
Objective: To investigate the clinical effect of atorvastatin combined with trimetazidine in the treatment of coronary heart disease. Methods: A retrospective analysis was performed on 76 patients with coronary heart disease undergoing cardiological treatment in our hospital from June 2010 to June 2014. According to the patients’ medication regimen, 38 patients were divided into control group and observation group respectively. Patients in control group Atorvastatin treatment, the treatment group was treated with atorvastatin combined with trimetazidine, compared the clinical efficacy of two groups of patients. Results: The effective rate of clinical treatment was 97.4% in the treatment group and 73.7% in the control group. The treatment effect in the treatment group was significantly better than that in the control group, and the difference was statistically significant (P <0.05). Conclusion: The clinical treatment of coronary heart disease with atorvastatin combined with trimetazidine treatment can significantly improve its clinical efficacy, it is worth to promote the clinical application.